GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » Intrinsic Value: Projected FCF

Beijing Airdoc Technology Co (HKSE:02251) Intrinsic Value: Projected FCF : HK$0.00 (As of Jun. 01, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-01), Beijing Airdoc Technology Co's Intrinsic Value: Projected FCF is HK$0.00. The stock price of Beijing Airdoc Technology Co is HK$15.00. Therefore, Beijing Airdoc Technology Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Beijing Airdoc Technology Co's Intrinsic Value: Projected FCF or its related term are showing as below:

HKSE:02251's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.26
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Beijing Airdoc Technology Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Beijing Airdoc Technology Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co Intrinsic Value: Projected FCF Chart

Beijing Airdoc Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
- - - - -

Beijing Airdoc Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Beijing Airdoc Technology Co's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, Beijing Airdoc Technology Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Airdoc Technology Co's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beijing Airdoc Technology Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Beijing Airdoc Technology Co's Price-to-Projected-FCF falls into.



Beijing Airdoc Technology Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Beijing Airdoc Technology Co  (HKSE:02251) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Beijing Airdoc Technology Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=15.00/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Airdoc Technology Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Airdoc Technology Co (HKSE:02251) Business Description

Traded in Other Exchanges
N/A
Address
West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.
Executives
Mialkos Tomasz Jakub 2101 Beneficial owner
Zhang Dalei 2501 Other
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Yadong Beichen Venture Investment Co., Ltd. 2101 Beneficial owner
Shanghai Ruikun Venture Capital Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun Industrial Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Chen Mingqiang 2501 Other
Gao Fei 2501 Other
Niagara Falls Holding Limited 2101 Beneficial owner
China Life Franklin Asset Management Co., Limited
China Life Insurance (group) Company

Beijing Airdoc Technology Co (HKSE:02251) Headlines

No Headlines